Peringkat dalam Saham
#26700
Operating internationally, including in Switzerland, Australia, Sweden, and the... Operating internationally, including in Switzerland, Australia, Sweden, and the United States, PharmAust Limited specializes in developing targeted cancer treatments for both human and animal applications. The company also cultivates intellectual property in drug discovery, addressing a range of cancers and neurological conditions. Its primary therapeutic candidate is Monepantel (MPL), a small molecule compound currently undergoing Phase II clinical trials for cancer treatment. Beyond its drug development pipeline, PharmAust provides synthetic and medicinal chemistry products and expert services to the global drug discovery and pharmaceutical sectors. The firm also holds a research agreement with the Walter and Eliza Hall Institute, investigating in vitro the effects of MPL on human T-lymphotrophic virus-1 (HTLV-1) infections. Established in 2000, PharmAust Limited is headquartered in Bentley, Australia.
Harga Saham
$0.12164306
Terakhir disinkronkan: 2024-11-11
Kapitalisasi Pasar
$38.53M
Perubahan (1 hari)
-4.14%
Perubahan (1 tahun)
0.00%
Perdagangan PharmAust Limited (PAA)
Harga PAA dengan kapitalisasi pasar B
Kapitalisasi pasar dari PharmAust Limited(PAA)
Kapitalisasi Pasar: $38.53M
Per August 2026, PharmAust Limited memiliki kapitalisasi pasar sebesar $38.53M. Ini menjadikan PharmAust Limited sebagai perusahaan 26700th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar PharmAust Limited dari 2001 hingga 2026
PAA dibandingkan dengan 5 teratas stocks paling populer
| Harga PAA |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.307T
|
+13,774,337.61%
|
|
|
|
|
$4.634T
|
+12,026,393.64%
|
|
|
|
|
$4.143T
|
+10,752,370.97%
|
|
|
|
|
$3.589T
|
+9,315,566.27%
|
|
|
|
|
$2.857T
|
+7,414,671.83%
|
